Latest Breaking News On - Prnewswire eilean therapeutics - Page 1 : comparemela.com

EILEAN THERAPEUTICS RECEIVES CLEARANCE TO INITIATE R/R AML TRIAL WITH LOMONITINIB, A SELECTIVE PAN-FLT3/IRAK4 INHIBITOR

EILEAN THERAPEUTICS RECEIVES CLEARANCE TO INITIATE R/R AML TRIAL WITH LOMONITINIB, A SELECTIVE PAN-FLT3/IRAK4 INHIBITOR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amy burdHuman research ethics committeeAi expert systems incEilean therapeuticsPrnewswire eilean therapeuticsChief executive officerTorrey pines investmentExpert systems inc

EILEAN THERAPEUTICS APPROVED TO INITIATE FIRST PATIENT TRIAL WITH BALAMENIB (ZE63-0302), A SELECTIVE BEST-IN-CLASS MENIN INHIBITOR

/PRNewswire/ Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule.

Johnc byrdAmy burdExpert systems incPrnewswire eilean therapeuticsEilean therapeutics australia pty ltdHuman research ethics committeeAustralian therapeutics goods administrationEilean therapeuticsEilean therapeutics australia ptyClinical trial notificationIain dukesChief executive officerEilean therapeuticTorrey pines investment

EILEAN THERAPEUTICS INITIATES FIRST IN HUMAN TRIAL WITH EILETOCLAX, A SELECTIVE BCL2 INHIBITOR WITH LIMITED IMMUNE SUPPRESSION AND IMPROVED SAFETY COMPARED TO VENETOCLAX AND VENETOCLAX-LIKE MOLECULES

/PRNewswire/ Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule.

Johnc byrdHuman research ethics committeeExpert systems incPrnewswire eilean therapeuticsEilean therapeuticsIain dukesChief executive officerTorrey pines investment

EILEAN THERAPEUTICS COMPLETES SINGLE DOSE STUDIES AND INITIATES MULTIPLE DOSING OF HEALTHY VOLUNTEERS WITH LOMONITINIB, A SELECTIVE PAN-FLT3/IRAK4 INHIBITOR

EILEAN THERAPEUTICS COMPLETES SINGLE DOSE STUDIES AND INITIATES MULTIPLE DOSING OF HEALTHY VOLUNTEERS WITH LOMONITINIB, A SELECTIVE PAN-FLT3/IRAK4 INHIBITOR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amy burdExpert systems incPrnewswire eilean therapeuticsEilean therapeuticsIain dukesChief executive officerTorrey pines investmentExpert systems